We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

266 hedge funds and large institutions have $4.24B invested in Immunogen Inc in 2023 Q2 according to their latest regulatory filings, with 101 funds opening new positions, 67 increasing their positions, 72 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

426% more capital invested

Capital invested by funds: $805M → $4.24B (+$3.43B)

304% more first-time investments, than exits

New positions opened: 101 | Existing positions closed: 25

93% more call options, than puts

Call options by funds: $69.3M | Put options by funds: $35.8M

40% more funds holding

Funds holding: 190 → 266 (+76)

7% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 72

Holders
266
Holders Change
+76
Holders Change %
+40%
% of All Funds
4.18%
Holding in Top 10
13
Holding in Top 10 Change
+13
Holding in Top 10 Change %
% of All Funds
0.2%
New
101
Increased
67
Reduced
72
Closed
25
Calls
$69.3M
Puts
$35.8M
Net Calls
+$33.4M
Net Calls Change
+$21.4M

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$114M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$103M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$74.2M
4
FFM
Fairmount Funds Management
Pennsylvania
+$71.2M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$70M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$231M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$201M
3
State Street
State Street
Massachusetts
-$108M
4
MC
Maverick Capital
Texas
-$48M
5
Morgan Stanley
Morgan Stanley
New York
-$47M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$34.2M +$2.97M +251,441 +16%
First Manhattan
27
First Manhattan
New York
$32.2M +$20.1M +1,700,000 +22,667%
Goldman Sachs
28
Goldman Sachs
New York
$30.4M -$7.12M -602,717 -27%
BBA
29
Baker Bros. Advisors
New York
$28.7M +$17.9M +1,520,097 New
SCM
30
Silverarc Capital Management
Massachusetts
$26.8M +$15M +1,270,000 +847%
QF
31
QVT Financial
New York
$25.9M – – –
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$24.8M +$7.76M +656,842 +100%
TCM
33
Tang Capital Management
California
$24.5M +$297K +25,147 +2%
EAM
34
Eventide Asset Management
Massachusetts
$24.5M +$15.3M +1,300,000 New
NIP
35
Nicholas Investment Partners
California
$23.1M +$14.5M +1,224,127 New
Renaissance Technologies
36
Renaissance Technologies
New York
$23M +$13.4M +1,138,900 +1,439%
PA
37
Pinnacle Associates
New York
$22.8M -$1.38M -116,556 -9%
Dimensional Fund Advisors
38
Dimensional Fund Advisors
Texas
$22.4M -$30.4K -2,578 -0.2%
Two Sigma Advisers
39
Two Sigma Advisers
New York
$22.4M -$20.6M -1,744,500 -60%
DCM
40
Driehaus Capital Management
Illinois
$22.2M +$13.9M +1,176,130 New
PAM
41
Panagora Asset Management
Massachusetts
$21.1M -$1.17M -99,173 -8%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$20.6M +$3.67M +310,960 +40%
Invesco
43
Invesco
Georgia
$19.5M +$10.1M +853,637 +469%
Balyasny Asset Management
44
Balyasny Asset Management
Illinois
$19.5M +$11M +929,828 +905%
CS
45
Candriam SCA
Luxembourg
$18.7M -$16.5M -1,396,714 -58%
Principal Financial Group
46
Principal Financial Group
Iowa
$18.6M +$11M +931,890 +1,664%
EA
47
Emerald Advisers
Pennsylvania
$18.6M +$11.6M +983,697 New
Citadel Advisors
48
Citadel Advisors
Florida
$17.5M -$553K -46,818 -5%
Lord, Abbett & Co
49
Lord, Abbett & Co
New Jersey
$17.3M +$10.9M +918,995 New
Connor, Clark & Lunn Investment Management (CC&L)
50
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$17.2M +$6.08M +514,941 +130%
1
2
3 4 5

IMGN Hedge Fund Activity: Q2 2023 in Review

266 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2023, worth a combined $4.24B — up 426% from $805M a quarter earlier.

Buyers outnumbered sellers: 101 funds opened new IMGN positions and 25 closed out — a net gain of 76 holders — while 67 added to existing stakes and 72 trimmed.

The largest buyer was Redmile Group, adding an estimated $114M. The largest seller was RA Capital Management, cutting an estimated $231M.

  • 266 institutional investors held Immunogen Inc (IMGN) as of Q2 2023, up from 190 in Q1 2023.
  • Funds reported $4.24B of Immunogen Inc stock for Q2 2023, up 426% quarter-over-quarter.
  • 101 funds opened new Immunogen Inc positions in Q2 2023 and 25 closed out, a net change of +76 holders.
  • The largest Immunogen Inc buyer in Q2 2023 was Redmile Group, an estimated $114M added.
  • The largest Immunogen Inc seller in Q2 2023 was RA Capital Management, an estimated $231M sold.

Based on aggregated 13F filings for Q2 2023.